Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Mexican Stock Exchange  >  Alpek SAB de CV    ALPEK A   MX01AL0C0004

ALPEK SAB DE CV (ALPEK A)
My previous session
Most popular
  Report  
End-of-day quote. End-of-day quote  - 12/18
23.66 MXN   -0.38%
10/10ALPEK SAB DE CV : quaterly earnings release
09/13ALPEK SAB DE CV : Close to new upside potential
2017ALPEK SAB DE CV : quaterly earnings release
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Alpek SAB de CV : Close to new upside potential

share with twitter share with LinkedIn share with facebook
share via e-mail
09/13/2018 | 06:05pm CET
long trade under condition
Target price hit
Entry price : 0MXN | Target : 31.83MXN | Stop-loss : 27.7MXN | Cancellation Level : 27MXN | Potential : INF%
Alpek SAB de CV shares are trading close to a major technical resistance, which, if broken, could yield new upside potential and an increase in volatility. This scenario can be anticipated.
Investors should benefit from the breakout of the MXN 28.75 level to target the MXN 31.83.
Chart ALPEK SAB DE CV
Duration : Period :
Alpek SAB de CV Technical Analysis Chart | MarketScreener
Full-screen chart
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • The stock, which is currently worth 2018 to 0.69 times its sales, is clearly overvalued in comparison with peers.
  • The company's attractive earnings multiples are brought to light by a P/E ratio at 11.55 for the current year.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The tendency within the weekly time frame is positive above the technical support level at 24.19 MXN

Weaknesses
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The company's earnings releases usually do not meet expectations.

David Meurisse
© Zonebourse.com 2018
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (MXN)
Sales 2018 132 B
EBIT 2018 13 199 M
Net income 2018 6 890 M
Debt 2018 25 370 M
Yield 2018 1,19%
P/E ratio 2018 7,18
P/E ratio 2019 9,15
EV / Sales 2018 0,57x
EV / Sales 2019 0,54x
Capitalization 50 081 M
Upcoming event on ALPEK SAB DE CV
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 36,5  MXN
Spread / Average Target 54%
EPS Revisions
Managers
NameTitle
José de Jesús Valdez Simancas Chief Executive Officer
Armando Garza Sada Chairman
José Carlos Pons Chief Financial Officer
Álvaro Fernández Garza Director
Francisco José Calderón Rojas Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ALPEK SAB DE CV0.90%2 498
DOWDUPONT-27.44%119 966
BASF-35.19%62 202
SASOL LIMITED-3.73%17 908
ROYAL DSM-8.42%15 076
GROUPE BRUXELLES LAMBERT-17.46%13 651